Instillo group consolidates an independent group of companies which operates over 20 countries world wide. It has established a strong network and built up a competitive team. It is a fast growing group with a wide range of pharmaceutical services from development through registration to commercialization, realised by the companies leon-nanodrugs GmbH and Quasaar GmbH. leon-nanodrugs holds the pharmaceutical licence of MJR technology for the development and registration of nanopharmaceuticals. Quasaar takes over the GMP relevant aspects of drug and formulation development and brings the products forward in the path of commercialization. Futhermore Instillo group companies extend their competence for the customers from food, cosmetics and technical particles by nanoSaar AG which is the exclusive licence holder of MJR technology for non-pharmaceuticals. Years of experience with MicroJet Reactor is translated into product excellence where innovative ideas are brought into the market.

Microjet reactor technology (MJR) for the production of nano- and microparticles

What we offer

MJR technology can develop and produce nano-/microparticles, emulsions and encapsulations with a well-defined size and very narrow size distribution and creates superior results compared to other technologies. A fully automated system is developed for fast and efficient optimization of formulations using QbD approach.
Nano- and microparticle production with MJR is controllable for all technical and physicochemical parameters and also cost effective to implement in large scales. Single MJR can yield 600L/min. MJR process overcome scale up problem by "numbering-up" : identical process parameters for lab, pilot and industrial batches.
MJR-production equipment fulfiling GMP requirements has been already developed. It enables robustness, IPC on-line, cleaning-/sterilzation-in-place.

What we are looking for

We are looking for partners who are interested by developing new formulation based on particles, or who are interested in transferring a bottom up particle formulation to Micorjet reactor technology to be able to easily scale up the production process and to transfer this process in a GMP environment.
We are also interested in Partner who are looking for a high quality production base for large quantity of micro- and/or nanoparticles for cosmetic, food or technical applications.


  • Pharma
    • [search] Distribution of drugs
    • [offer] Drug targeting and delivery
    • [offer & search] Equipment & Devices
    • [offer] Galenics
    • [search] Pharmacokinetics
    • [search] Pharmacology
    • [search] Toxicology
  • Biotech
    • [search] Biological & Chemical Sciences
    • [search] Biopharmaceuticals
    • [offer] Diagnostics & Therapy (Diseases)
    • [offer] Drug Delivery/Drug Targeting
    • [offer] Nanobiotechnology
  • Components and Services
    • [offer] Consulting and support
    • [offer] Contract development
    • [offer] Contract research
    • [search] Laboratory equipment and services
    • [search] Manufacturing services
    • [offer] Nano- and surface technologies

Collaboration sought

  • Research & development
  • Series production
  • Laboratory services
  • Partnership for international development projects
  • Financing



Quasaar CEO

back to list